Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors

Author:

Shiozaki Makoto1,Maeda Katsuya1,Miura Tomoya1,Kotoku Masayuki1,Yamasaki Takayuki1,Matsuda Isamu1,Aoki Kenta1,Yasue Katsutaka1,Imai Hiroto1,Ubukata Minoru1,Suma Akira1,Yokota Masahiro1,Hotta Takahiro1,Tanaka Masahiro1,Hase Yasunori1,Haas Julia2,Fryer Andrew M.2,Laird Ellen R.2,Littmann Nicole M.2,Andrews Steven W.2,Josey John A.2,Mimura Takayuki3,Shinozaki Yuichi3,Yoshiuchi Hiromi3,Inaba Takashi1

Affiliation:

1. Chemical Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan

2. Array BioPharma Inc., 3200 Walnut Street, Boulder, Colorado 80301, United States

3. Biological Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3